Targretin and Staphylococcal bacteraemia - a phase IV clinical study of FDA data

Summary:

Staphylococcal bacteraemia is reported as a side effect among people who take Targretin (bexarotene), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Gemcitabine, and have Hypertriglyceridaemia.

The phase IV clinical study analyzes which people have Staphylococcal bacteraemia when taking Targretin. It is created by eHealthMe based on reports of 1,056 people who have side effects when taking Targretin from the FDA, and is updated regularly.

What is Targretin?

Targretin has active ingredients of bexarotene. eHealthMe is studying from 1,064 Targretin users. Check the latest studies of Targretin.

What is Staphylococcal bacteraemia?

Staphylococcal bacteraemia (a bacterial infection of blood) is found to be associated with 610 drugs and 667 conditions by eHealthMe. Check the latest studies of Staphylococcal bacteraemia.

On Jul, 17, 2026

1,056 people reported to have side effects when taking Targretin.
Among them, 12 people (1.14%) have Staphylococcal bacteraemia.

Could Targretin cause Staphylococcal bacteraemia?

Among these 12 people:

How long have people been on Targretin when they have Staphylococcal bacteraemia? *

What is the gender of people who have Staphylococcal bacteraemia when taking Targretin? *

female: 27.27 %
male: 72.73 %

What is the age of people who have Staphylococcal bacteraemia when taking Targretin? *

What are other drugs people take besides Targretin? *

What are other side effects people have besides Staphylococcal bacteraemia? *

Weight Decreased: 9 people, 75.00%
Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 8 people, 66.67%
Hypertriglyceridaemia (excess of triglycerides in the blood): 7 people, 58.33%
Drug Ineffective: 6 people, 50.00%
Hair Loss: 5 people, 41.67%
Dermatitis Psoriasiform (large white or silver flakes on the skin): 5 people, 41.67%
Chronic Kidney Disease: 5 people, 41.67%
Septic Shock (shock due to blood infection): 5 people, 41.67%
Skin Plaque (red, scaly patches to appear on the skin): 5 people, 41.67%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 25.00%

What are the existing conditions these people have? *

Hypertriglyceridaemia (excess of triglycerides in the blood): 6 people, 50.00%
Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 5 people, 41.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 41.67%
Immunodeficiency Disorders: 4 people, 33.33%
Skin Cancer: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Targretin and have Staphylococcal bacteraemia?

- Check whether Staphylococcal bacteraemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Targretin:

Targretin (1,064 reports)

Browse all side effects of Targretin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Staphylococcal bacteraemia:

Staphylococcal bacteraemia (610 drugs)

Browse all the conditions that are associated with Staphylococcal bacteraemia:

Staphylococcal bacteraemia (667 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bexarotene (the active ingredients of Targretin) and Targretin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.